SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial

Srividya Kakulavarapu; Dessy Boneva; Adel Elkbuli

doi:10.1016/j.amsu.2021.01.098

SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial

Ann Med Surg (Lond). 2021 Feb:62:460-462. doi: 10.1016/j.amsu.2021.01.098. Epub 2021 Feb 1.

Authors

Srividya Kakulavarapu¹, Dessy Boneva^{1

2}, Adel Elkbuli¹

Affiliations

¹ Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA.
² Department of Surgery, University of South Florida, Tampa, FL, USA.

Abstract

•All three vaccines have substantial efficacy in preventing symptomatic and severe Sars-CoV-2 infection.•Vaccine dissemination is important due to the rapid mutagenic nature of the virus and continuing decline in the health and economies around the world.•Further attempts to achieve widespread access of the vaccine is vital for all preventative measures to be maximally successful.

Publication types

Editorial